Stockscreener 앱 받기
27.79
1.07%
-0.30
전일 마감가:
$28.09
열려 있는:
$27.97
하루 거래량:
887.51K
Relative Volume:
0.70
시가총액:
$1.55B
수익:
$249.12M
순이익/손실:
$-90.19M
주가수익비율:
-16.35
EPS:
-1.7
순현금흐름:
$-88.21M
1주 성능:
-3.31%
1개월 성능:
-9.12%
6개월 성능:
-31.18%
1년 성능:
-59.88%
1일 변동 폭
$27.56
$28.86
1주일 범위
$26.93
$30.02
52주 변동 폭
$26.66
$70.80
Procept Biorobotics Corp Stock (PRCT) Company Profile
명칭
Procept Biorobotics Corp
전화
(650) 232-9832
주소
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
27.79 | 1.57B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-12 | 개시 | UBS | Buy |
| 2025-12-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-09-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-07-09 | 개시 | Stephens | Overweight |
| 2025-07-07 | 개시 | Oppenheimer | Perform |
| 2024-12-02 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 개시 | Jefferies | Hold |
| 2023-08-11 | 개시 | Piper Sandler | Overweight |
| 2023-05-31 | 개시 | William Blair | Outperform |
| 2022-10-31 | 개시 | BTIG Research | Neutral |
| 2022-10-25 | 개시 | Truist | Buy |
| 2022-09-02 | 개시 | Wells Fargo | Overweight |
| 2022-07-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Goldman | Neutral |
| 2021-10-11 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | SVB Leerink | Outperform |
모두보기
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
Is PROCEPT BioRobotics Corporation stock a buy or sellDay Trade & Free Community Supported Trade Ideas - mfd.ru
Does PROCEPT BioRobotics Corporation stock reflect fundamentalsJuly 2025 Outlook & Daily Chart Pattern Signal Reports - mfd.ru
Why PROCEPT BioRobotics Corporation stock is favored by pension fundsJuly 2025 Review & Risk Managed Trade Strategies - mfd.ru
Wall Street Has a Positive Opinion on PROCEPT BioRobotics (PRCT), Here's Why - Finviz
Wall Street Has a Positive Opinion on PROCEPT BioRobotics (PRCT), Here’s Why - Insider Monkey
Income Plays: Should I buy PROCEPT BioRobotics Corporation stock now2025 Market Outlook & Weekly Stock Breakout Alerts - baoquankhu1.vn
Is PROCEPT BioRobotics Corporation stock resilient to inflationJuly 2025 Sector Moves & Weekly Setup with ROI Potential - mfd.ru
PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Unpacking a 73.66% Potential Upside - DirectorsTalk Interviews
Buyout Rumor: What hedge funds are buying PROCEPT BioRobotics CorporationJuly 2025 Volume & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
C WorldWide Group Holding A S Invests $5.35 Million in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Hits New 1-Year LowWhat's Next? - MarketBeat
Procept Biorobotics stock hits 52-week low at 27.79 USD - Investing.com
PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference - The Manila Times
PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual - GlobeNewswire
Key Dates for Procept BioRobotics Investors - AD HOC NEWS
PROCEPT BioRobotics (PRCT) Stock Analysis: A 74% Potential Upside in the Medical Robotics Field - DirectorsTalk Interviews
After a 60% Slide, One Fund Cuts Exposure to This Healthcare Tech Stock by $12.5 Million - The Motley Fool
PROCEPT BioRobotics Corporation $PRCT Stock Position Lowered by Federated Hermes Inc. - MarketBeat
A Look At PROCEPT BioRobotics (PRCT) Valuation After Mixed Recent Share Price Returns - Yahoo Finance
PROCEPT BioRobotics to Report Q4 2025 Financial Results and Host Investor Day Event in February 2026 - Quiver Quantitative
PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City - The Manila Times
Surgery robot firm PROCEPT plans Feb. 25 investor day at Nasdaq HQ - Stock Titan
Did AquaBeam Milestones and Options Activity Just Shift PROCEPT BioRobotics' (PRCT) Investment Narrative? - simplywall.st
A Look At PROCEPT BioRobotics (PRCT) Valuation As Regulatory And Clinical Catalysts Draw Investor Focus - Sahm
First Week of March 20th Options Trading For PROCEPT BioRobotics (PRCT) - InteractiveCrypto
Will PROCEPT BioRobotics Corporation benefit from current market trendsBreakout Watch & Expert-Curated Trade Recommendations - bollywoodhelpline.com
Promising growth forecasts leading to analysts’ optimism for Procept Biorobotics (PRCT) - msn.com
FMR LLC Reduces Stake in PROCEPT BioRobotics Corp by 42.10% - GuruFocus
US Market Wrap: What risks investors should watch in PROCEPT BioRobotics Corporation stock - Bộ Nội Vụ
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Assessing PROCEPT BioRobotics (PRCT) Valuation As Fresh Analyst Downgrade Meets Confident Long-Term Growth Views - simplywall.st
Peregrine Capital Management LLC Purchases Shares of 188,219 PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Will PROCEPT BioRobotics Corporation stock outperform value stocksJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - Улправда
Procept BioRobotics initiated with a buy at UBS - MSN
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 7.1%Here's Why - MarketBeat
Is Wall Street’s Split View On PROCEPT BioRobotics (PRCT) Revealing Aquablation’s True Strategic Position? - simplywall.st
Truist Maintains Buy Rating on Procept BioRobotics (PRCT) Amid MedTech Sector Rotation - Finviz
Will PROCEPT BioRobotics Corporation stock return to pre crisis levels2025 Investor Takeaways & Capital Protection Trading Alerts - Улправда
ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now? - Nasdaq
PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: A 53% Potential Upside in the Surgical Robotics Arena - DirectorsTalk Interviews
PROCEPT BioRobotics Corporation $PRCT Shares Purchased by Chicago Capital LLC - MarketBeat
PROCEPT BioRobotics Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Best Robotics Stocks To ConsiderDecember 26th - MarketBeat
How Investors Are Reacting To PROCEPT BioRobotics (PRCT) UBS Coverage Initiation And 2027 Profitability Outlook - simplywall.st
Procept Biorobotics Corp (PRCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Procept Biorobotics Corp 주식 (PRCT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| MOLL FREDERIC H | Director |
Aug 13 '25 |
Buy |
39.26 |
20,000 |
785,138 |
863,159 |
| Nouri Alaleh | EVP, CLO, CORP. SEC. |
Aug 14 '25 |
Option Exercise |
4.52 |
11,000 |
49,720 |
72,473 |
| Desai Antal Rohit | Director |
Jun 10 '25 |
Sale |
63.91 |
25,000 |
1,597,711 |
64,363 |
| Desai Antal Rohit | Director |
Jun 11 '25 |
Sale |
63.38 |
25,000 |
1,584,525 |
39,363 |
| Desai Antal Rohit | Director |
Jun 12 '25 |
Sale |
61.49 |
25,000 |
1,537,256 |
14,363 |
1.33%
0.51%
자본화:
|
볼륨(24시간):